Belgian (BEL20) Growth Pharmaceuticals & Biotech Stocks
UPDATED Mar 24, 2026
Discover Belgian Pharmaceuticals & Biotech Growth Stocks that are on the BEL20. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
HYL | €5.20 | -12.8% | -17.5% | €145.6m | €13.57 | 17.2 | 79.9% | n/a | ||
ARGX | €583.20 | -5.3% | 4.3% | €36.2b | €839.27 | 32.5 | 21.6% | n/a | ||
UCB | €247.40 | -4.1% | 41.2% | €47.1b | €284.85 | 30.2 | 17.3% | 0.6% | ||
TUB | €209.00 | -3.9% | 53.7% | €9.3b | €251.50 | 99.8 | n/a | 0.5% | ||
OXUR | €0.005 | -13.8% | -97.0% | €350.5k | n/a | 0.2 | n/a | n/a | ||
BIOS | €0.0023 | 0% | 0% | €1.5m | n/a | -0.4 | n/a | n/a | ||
ALEMS | €5.05 | 3.1% | -12.9% | €21.4m | n/a | 18.2 | n/a | n/a | ||
CYAD | €0.32 | 2.9% | -44.8% | €14.3m | n/a | 77.0 | n/a | n/a |
Page 1 of 1